ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 710549 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 710549; 2) Community: the network communities that were significantly associated with the response to NSC 710549; 3) Molecule: the relationships between components within communities and NSC 710549; 4) MDR: the compounds that were significantly associated with the NSC 710549.

NSC Compound Enrichment Correlation
NSC 355457 11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride 0.00824865245912282 0.40027119
NSC 642968 Benzo[g]quinoline-5,10-dione, 5,10-dihydro- 4-[2-(1-piperidinyl)ethenyl]- 0.00824865245912282 -0.15178256
NSC 685981 1,4-Butanediamine, N,N'-bis[(2-naphthalenyl)methyl- N,N'-bis[3-[(trifluoroacetyl)amino]propyl]- 0.00824865245912282 -0.030490575
NSC 105014 Cladribine 0.00824865245912294 0.086555764
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.00824865245912294 0.29144246
NSC 163443 Null 0.00824865245912294 0.25085079
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.00824865245912294 0.40896112
NSC 636969 Null 0.00824865245912294 0.3963144
NSC 63878 Cytarabine Hydrochloride AZ 0.00824865245912294 0.31872883
NSC 643836 Null 0.00824865245912294 -0.17914032
Total:84  Current:16    [First] [Prev] [Next] [Last]